Jaguar Health (JAGX) Liabilities and Shareholders Equity (2014 - 2026)

Jaguar Health (JAGX) has 13 years of Liabilities and Shareholders Equity data on file, last reported at $37.4 million in Q1 2026.

• Liabilities and Shareholders Equity for Q1 2026 came in at $37.4 million, down 27.26% year-over-year; the trailing twelve-month figure through Mar 2026 was $173.5 million (down 22.83% YoY), and the FY2025 annual result was $38.3 million, down 28.27% from the prior year.
• Liabilities and Shareholders Equity declined to $37.4 million in Q1 2026 per JAGX's latest filing, from $38.3 million in the prior quarter.
• Over five years, Liabilities and Shareholders Equity peaked at $61.5 million in Q2 2024 and troughed at $37.4 million in Q1 2026.
• A 5-year average of $50.6 million and a median of $51.3 million in 2022 frame the typical range for Liabilities and Shareholders Equity.
• The sharpest annual moves came in 2024 and 2025: Liabilities and Shareholders Equity increased 28.84% in 2024, then dropped 28.27% in 2025.
• A 5-year view of Liabilities and Shareholders Equity shows it stood at $47.5 million in 2022, then climbed by 6.98% to $50.8 million in 2023, then rose by 5.24% to $53.4 million in 2024, then retreated by 28.27% to $38.3 million in 2025, then dropped by 2.32% to $37.4 million in 2026.
• Business Quant data shows JAGX's Liabilities and Shareholders Equity at $37.4 million in Q1 2026, $38.3 million in Q4 2025, and $49.5 million in Q3 2025.